Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ILOPROST vs IMIQUIMOD: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ILOPROST vs IMIQUIMOD: Safety Overview

Metric ILOPROST IMIQUIMOD
Total FAERS Reports 4,961 1,689
Deaths Reported 2,277 25
Death Rate 45.9% 1.5%
Hospitalizations 2,324 154
Average Patient Age 57.9 yrs 62.3 yrs
% Female Patients 70.7% 52.1%
FDA Approval Date Aug 7, 2009 Apr 15, 2011
Manufacturer BTG International Inc Padagis Israel Pharmaceuticals Ltd
Route INTRAVENOUS TOPICAL
Marketing Status Discontinued Discontinued